Likewise, Nexturastat A was reported to improve the immune checkpoint blockade of antitumor immune response and diminish the aggressiveness of breast cancer cells with minimal cytotoxic effects by specifically targeting HDAC6 in breast cancer [200–202]. The gene discussed is HDAC6; the disease is breast carcinoma.